Home›Search›Medicine in Drug Discovery

Medicine in Drug Discovery

Elsevier B.V. · Netherlands · Est. 2019

ISSN2590-0986

SJR Q1✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q178

✓ Corroboration (1 more)+6

Total84

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 25% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

1.145

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.892

Total Worksi

240

Total Citationsi

5,902

2yr Mean Citednessi

5.18

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Medicine in Drug Discovery is a peer-reviewed, open access journal that publishes original papers related to basic, preclinical, and clinical studies covering all aspects of drug discovery and development. Its scope includes drug delivery, medicinal chemistry, drug development and commercialization, translational science, cell therapy, efficacy and safety, target engagement, and biomarkers.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionNetherlands

Primary LanguageEnglish

1st Year Published2019

Annual Volume~ 30 articles / year

StatusActive (last: 2026)

Total Publications240

Publisher OrgElsevier BV

OA Since2018

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~10 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Elsevier B.V.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2590-0986

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

593

2019

2.7k

2020

1.1k

2021

851

2022

451

2023

239

2024

304

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ1

PharmacologyQ1

Pharmacology (medical)Q1

Subject Classification

Scopus Categories

PharmacologyPharmacology (medical)Drug Discovery

Frequently asked questions about Medicine in Drug Discovery

Is Medicine in Drug Discovery a predatory journal?

PubScope has no integrity flags on record for Medicine in Drug Discovery: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 84/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Medicine in Drug Discovery?

Medicine in Drug Discovery is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 1.145.

Is Medicine in Drug Discovery indexed in Scopus and Web of Science?

Medicine in Drug Discovery is indexed in Scopus, DOAJ.